Key information

🔎 Fund Overview

FOXO Technologies Inc. is a biotechnology company. The Company is focused on improving human health and longevity through the development of cutting-edge technology and product solutions for various industries, including life insurance. Its epigenetic technology applies artificial intelligence (AI) to deoxyribonucleic acid (DNA) methylation to identify molecular biomarkers of human health and aging. Its FOXO Labs segment performs research and development and is commercializing proprietary epigenetic biomarker technology. Its concentrating efforts on Bioinformatics Services offering, a suite of bioinformatic tools to help researchers process, analyze, and interpret epigenetic data and research and development in the fields of health and wellness testing powered by machine learning and AI (including a potential AI platform for the delivery of health and well-being data-driven insights to individuals, healthcare professionals and third-party service providers).